| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 116, 503-510, Copyright © 1985 by Endocrine Society
ARTICLES |
HL Henry
In order to determine whether cAMP mediates the effects of PTH on the metabolism of 25-hydroxyvitamin D3 (25-OH-D3) on chick kidney cells in primary culture, the effect of forskolin on the production of 1,25- dihydroxyvitamin D3 [1,25-(OH)2D3] and 24,25-dihydroxyvitamin D3 [24,25- (OH)2D3] was assessed. In 4-h incubations with [3H]25-OH-D3 and forskolin, (1-10 microM) [3H]1,25-(OH)2D3 accumulation was increased 50- 100%, and that of [3H]24,25-(OH)2D3 was decreased 30-60%. PTH (1-10 ng/ml) brought about identical changes. Similar results were observed when cultures were preincubated with nonradioactive 25-OH-D3 for 4 h in the presence of PTH and forskolin, followed by a 30-min incubation with radioactive substrate. At a low concentration (0.05 microM), forskolin alone had no effect on the metabolism of [3H]25-OH-D3 but markedly enhanced that of PTH. At maximal concentrations of PTH (10 ng/ml) and forskolin (10 microM), the effects of the two on 25-OH-D3 metabolism were not additive. Both PTH and forskolin decreased the further metabolism of [3H]1,25-(OH)2D3, probably by inhibiting its 24- hydroxylation, but there are also cycloheximide-sensitive steps in the metabolism of 1,25-(OH)2D3 that are not affected by PTH and forskolin. In time course experiments, increased [3H]1,25-(OH)2D3 accumulation could be observed before the detection of 24-hydroxylase activity suggesting that the primary effect of PTH and forskolin is on the production of [3H] 1,25-(OH)2D3 rather than its catabolism. Raising the calcium concentration of the medium to 2.5 mM from the normal 1.8 mM or lowering it to 0.5 mM for 24 h in serum-free medium did not alter the response of 25-OH-D3 metabolism to these agents. The results of these studies indicate that the effects of PTH on the metabolism of 25-OH-D3 by chick kidney cells are mediated by cAMP, since they can be enhanced and mimicked by forskolin, that they are exerted at the level of both 1- and 24-hydroxylase activity, and that they are not dependent on the calcium concentration of the medium.
This article has been cited by other articles:
![]() |
A. Maiti, N. C. Hait, and M. J. Beckman Extracellular Calcium-sensing Receptor Activation Induces Vitamin D Receptor Levels in Proximal Kidney HK-2G Cells by a Mechanism That Requires Phosphorylation of p38{alpha} MAPK J. Biol. Chem., January 4, 2008; 283(1): 175 - 183. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. L. Dudas, A. R. Villalobos, G. Gocek-Sutterlin, G. Laverty, and J. L. Renfro Regulation of transepithelial phosphate transport by PTH in chicken proximal tubule epithelium Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2002; 282(1): R139 - R146. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. YOSHIDA, T. YOSHIDA, A. NAKAMURA, T. MONKAWA, M. HAYASHI, and T. SARUTA Calcitonin Induces 25-Hydroxyvitamin D3 1{alpha}-Hydroxylase mRNA Expression via Protein Kinase C Pathway in LLC-PK1 Cells J. Am. Soc. Nephrol., December 1, 1999; 10(12): 2474 - 2479. [Abstract] [Full Text] |
||||
![]() |
R. Bland, E. A. Walker, S. V. Hughes, P. M. Stewart, and M. Hewison Constitutive Expression of 25-Hydroxyvitamin D3-1{alpha}-Hydroxylase in a Transformed Human Proximal Tubule Cell Line: Evidence for Direct Regulation of Vitamin D Metabolism by Calcium Endocrinology, May 1, 1999; 140(5): 2027 - 2034. [Abstract] [Full Text] |
||||
![]() |
A. Murayama, K.-i. Takeyama, S. Kitanaka, Y. Kodera, Y. Kawaguchi, T. Hosoya, and S. Kato Positive and Negative Regulations of the Renal 25-Hydroxyvitamin D3 1{alpha}-Hydroxylase Gene by Parathyroid Hormone, Calcitonin, and 1{alpha},25(OH)2D3 in Intact Animals Endocrinology, May 1, 1999; 140(5): 2224 - 2231. [Abstract] [Full Text] |
||||
![]() |
W. Yang, P. A. Friedman, R. Kumar, J. L. Omdahl, B. K. May, M.-L. Siu-Caldera, G. S. Reddy, and S. Christakos Expression of 25(OH)D3 24-hydroxylase in distal nephron: coordinate regulation by 1,25(OH)2D3 and cAMP or PTH Am J Physiol Endocrinol Metab, April 1, 1999; 276(4): E793 - E805. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. L. Brenza, C. Kimmel-Jehan, F. Jehan, T. Shinki, S. Wakino, H. Anazawa, T. Suda, and H. F. DeLuca Parathyroid hormone activation of the 25-hydroxyvitamin D3-1alpha -hydroxylase gene promoter PNAS, February 17, 1998; 95(4): 1387 - 1391. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |